Pharsight

Drugs that contain Pitavastatin Calcium

1. Livalo patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8557993 KOWA CO Crystalline forms of pitavastatin calcium
Feb, 2024

(22 days ago)

US7022713 KOWA CO Hyperlipemia therapeutic agent
Feb, 2024

(5 days ago)

US8557993

(Pediatric)

KOWA CO Crystalline forms of pitavastatin calcium
Aug, 2024

(5 months from now)

US7022713

(Pediatric)

KOWA CO Hyperlipemia therapeutic agent
Aug, 2024

(5 months from now)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population (NPP) May 16, 2022
Pediatric Exclusivity (PED) Nov 16, 2022

Market Authorisation Date: 03 August, 2009

Treatment: Adjuncitve therapy to diet to reduce elevated total cholesterol, low-density lipoprotein cholesterol, apolipoprotein b, triglycerides and to increase hdl-c in adult patients with primary hyperlipidemi...

Dosage: TABLET;ORAL

How can I launch a generic of LIVALO before it's drug patent expiration?
More Information on Dosage

LIVALO family patents

Family Patents